Insider trade

CEO sold ~$2.38M of AIP shares in the open market

Traded Oct 1, 2026 · Filed Oct 6, 2026

~$2.38M
Approx. value · 100K sh @ $23.82: 8.13M
Holds after · shares reported: +0.5%
Since filing · from the first close after the filing, $24.01 → $24.13 on Oct 6, S&P 500 +2.0%

Why it stands out

The CEO of Arteris sold $2.38M of Arteris shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CEOIndirect holding$1M+Pre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$2,382,390

Shares × reported transaction price

Timing vs results

56 days after results of Aug 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.43 to $24.23 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.